ImmunityBio, Inc. — Director's Dealing 2018

Jun 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2018-05-30

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-30	Common Stock	S	2724	$3.8781	Disposed	401176	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	246280	Direct

Footnotes

F1: Represents the weighted average share price of an aggregate total of 2,724 shares sold in the price range of $3.86 to $3.89 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.